Cardiothoracic & vascular anesthesia

Effects of naloxegol on transit recovery in patients undergoing cardiac surgery: A randomized, double-blind, placebo-controlled trial

Anaesth Crit Care Pain MedPublished Randomised controlled trial

Authors' conclusion

Naloxegol was not found to be effective in improving the transit time recovery after elective cardiac surgery.

Study context

Population
Patients over 18 years old undergoing non-urgent cardiac surgerymodified ITT analysis
Participants
299 participants
Comparison
Naloxegol vs matching placebo
Primary endpoint
Time to postoperative gastrointestinal transit recovery (hours from anaesthetic induction to first significant stool)
Methodological detailssingle-centre, double-blind, placebo-controlled, phase 3
  • Single-centre
  • Double-blind
  • Placebo-controlled
  • Phase 3

Primary result

As reported in the abstract

P = 0.40

Secondary outcomes

Prespecified secondary efficacy endpoints

No difference between groups

Safety

Pain levels and serious adverse events

Not different in both groups

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effects of naloxegol on transit recovery in patients undergoing cardiac surgery: A randomized, double-blind, placebo-controlled trial. Anaesth Crit Care Pain Med. Published 21 February 2025. doi:10.1016/j.accpm.2025.101498

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.